ReviewSAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance2016
Zimbabwe's national AIDS levy: A case study.
Review in SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Ideas matter: An analysis of the effects of framing on health system strengthening in Zimbabwe.Health research policy and systems · 2025Article
- The Precarious Future of HIV and AIDS Programs in Zimbabwe Following International Funding Freeze: Impact and Strategic Interventions.Journal of epidemiology and global health · 2025Article
- Women Living with HIV in Zimbabwe: Their Stigma-Related Emotional Life and Sense of Self.International journal of environmental research and public health · 2025Article
- Towards a sustainable HIV response: strengthening Zimbabwe's domestic financing for HIV programs amid declining donor support.Frontiers in health services · 2025Article
- 'We thought supporting was strengthening': re-examining the role of external assistance for health systems strengthening in Zimbabwe post-COVID-19.Health policy and planning · 2024Article
- Strengthening and enhancing national antiretroviral drug resistance surveillance in Zimbabwe-A country that has reached UNAIDS 95-95-95 amongst adults.Frontiers in public health · 2024Article
- The nature and contribution of innovative health financing mechanisms in the World Health Organization African region: A scoping review.Journal of global health · 2023Article
- Inequality and private health insurance in Zimbabwe: history, politics and performance.International journal for equity in health · 2023Review
- Governing a pandemic: biopower and the COVID-19 response in Zimbabwe.BMJ global health · 2022Review
- The political economy of health financing reforms in Zimbabwe: a scoping review.International journal for equity in health · 2022Article
- Gender Inequality, Health Rights, and HIV/AIDS among Women Prisoners in Zimbabwe.Health and human rights · 2021Article
- Model strategies to address barriers to cervical cancer treatment and palliative care among women in Zimbabwe: a public health approach.BMC women's health · 2021Article
- Assessment of the transport management systems for National Acquired Immunodeficiency Syndrome (AIDS) Council of Zimbabwe Global Fund Round 8 grant sub-recipients and implementing partners, 2014.The Pan African medical journal · 2020Article
- Leveraging the lessons learned from financing HIV programs to advance the universal health coverage (UHC) agenda in the East African Community.Global health research and policy · 2019Review
- A longitudinal review of national HIV policy and progress made in health facility implementation in Eastern Zimbabwe.Health research policy and systems · 2018Article
- HIV: from exceptionalism to endgame.Lancet (London, England) · 2018Article
- Alternative financing mechanisms for ART programs in health facilities in Uganda: a mixed-methods approach.BMC health services research · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundWe conducted a case study of the Zimbabwe National AIDS Trust Fund ('AIDS Levy') as an approach to domestic government financing of the response to HIV and AIDS.
methodsData came from three sources: a literature review, including a search for grey literature, review of government documents from the Zimbabwe National AIDS Council (NAC), and key informant interviews with representatives of the Zimbabwean government, civil society and international organizations.
findingsThe literature search yielded 139 sources, and 20 key informants were interviewed. Established by legislation in 1999, the AIDS Levy entails a 3% income tax for individuals and 3% tax on profits of employers and trusts (which excluded the mining industry until 2015). It is managed by the parastatal NAC through a decentralized structure of AIDS Action Committees. Revenues increased from inception to 2006 through 2008, a period of economic instability and hyperinflation. Following dollarization in 2009, annual revenues continued to increase, reaching US$38.6 million in 2014. By policy, at least 50% of funds are used for purchase of antiretroviral medications. Other spending includes administration and capital costs, HIV prevention, and monitoring and evaluation. Several financial controls and auditing systems are in place. Key informants perceived the AIDS Levy as a 'homegrown' solution that provided country ownership and reduced dependence on donor funding, but called for further increased transparency, accountability, and reduced administrative costs, as well as recommended changes to increase revenue.
conclusionsThe Zimbabwe AIDS Levy has generated substantial resources, recently over US$35 million per year, and signals an important commitment by Zimbabweans, which may have helped attract other donor resources. Many key informants considered the Zimbabwe AIDS Levy to be a best practice for other countries to follow.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.